Cargando…

What Is Known about Theragnostic Strategies in Colorectal Cancer

Despite the paradigmatic shift occurred in recent years for defined molecular subtypes in the metastatic setting treatment, colorectal cancer (CRC) still remains an incurable disease in most of the cases. Therefore, there is an urgent need for new tools and biomarkers for both early tumor diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parisi, Alessandro, Porzio, Giampiero, Pulcini, Fanny, Cannita, Katia, Ficorella, Corrado, Mattei, Vincenzo, Delle Monache, Simona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912746/ https://www.ncbi.nlm.nih.gov/pubmed/33535557 http://dx.doi.org/10.3390/biomedicines9020140

Ejemplares similares

Topical Menthol for Treatment of Chemotherapy-induced Peripheral Neuropathy
por: Cortellini, Alessio, et al.
Publicado: (2017)

Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain–Barré Syndrome
por: Cortellini, Alessio, et al.
Publicado: (2018)

Multimodality Treatment in Metastatic Gastric Cancer: From Past to Next Future
por: Parisi, Alessandro, et al.
Publicado: (2020)

Regenerative Potential of DPSCs and Revascularization: Direct, Paracrine or Autocrine Effect?
por: Mattei, Vincenzo, et al.
Publicado: (2021)

Methylglyoxal-Dependent Glycative Stress Is Prevented by the Natural Antioxidant Oleuropein in Human Dental Pulp Stem Cells through Nrf2/Glo1 Pathway
por: Delle Monache, Simona, et al.
Publicado: (2021)

Single‐institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non‐small cell lung cancer patients treated with first‐line chemotherapy
por: Cortellini, Alessio, et al.
Publicado: (2018)

Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non‐small cell lung cancer patients: A “hypothesis‐generator” preliminary report
por: Cortellini, Alessio, et al.
Publicado: (2019)

Gangliosides and Their Role in Multilineage Differentiation of Mesenchymal Stem Cells
por: Santilli, Francesca, et al.
Publicado: (2022)

“Vessels in the Storm”: Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer
por: Angelucci, Adriano, et al.
Publicado: (2018)

Safe Administration of anti-PD-L1 Atezolizumab in a Patient with Metastatic Urothelial Cell Carcinoma and End-Stage Renal Disease on Dialysis
por: Parisi, Alessandro, et al.
Publicado: (2019)

Antioxidant Properties of Cerium Oxide Nanoparticles Prevent Retinal Neovascular Alterations In Vitro and In Vivo
por: Tisi, Annamaria, et al.
Publicado: (2022)

Physical Exercise and Quality of Life in Breast Cancer Survivors
por: VALENTI, Marco, et al.
Publicado: (2008)

Hypoxia Induces DPSC Differentiation versus a Neurogenic Phenotype by the Paracrine Mechanism
por: Delle Monache, Simona, et al.
Publicado: (2022)

Dental Pulp Stem Cells (DPSCs) and Tissue Regeneration: Mechanisms Mediated by Direct, Paracrine, or Autocrine Effects
por: Mattei, Vincenzo, et al.
Publicado: (2023)

10th Anniversary of Biomedicines—Advances in Mesenchymal Stem Cells
por: Mattei, Vincenzo, et al.
Publicado: (2023)

Concurrent RAS and RAS/BRAF V600E Variants in Colorectal Cancer: More Frequent Than Expected? A Case Report
por: Zelli, Veronica, et al.
Publicado: (2022)

Prognostic relevance of KRAS genotype in metastatic colorectal cancer patients unfit for FIr-B/FOx intensive regimen
por: BRUERA, GEMMA, et al.
Publicado: (2014)

Effectiveness and Safety of Intensive Triplet Chemotherapy Plus Bevacizumab, FIr-B/FOx, in Young-Elderly Metastatic Colorectal Cancer Patients
por: Bruera, Gemma, et al.
Publicado: (2013)

Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma
por: Colapietro, Alessandro, et al.
Publicado: (2021)

Differential prognosis of metastatic colorectal cancer patients post-progression to first-line triplet chemotherapy plus bevacizumab, FIr-B/FOx, according to second-line treatment and KRAS genotype
por: BRUERA, GEMMA, et al.
Publicado: (2013)

The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis-generator’ study from clinical practice
por: Cortellini, Alessio, et al.
Publicado: (2018)

Lipid rafts mediate multilineage differentiation of human dental pulp-derived stem cells (DPSCs)
por: Santilli, Francesca, et al.
Publicado: (2023)

Cancer Care After Natural Disaster: Different Countries, Similar Problems
por: Verna, Lucilla, et al.
Publicado: (2019)

Looking for A Place for Dose-Dense TMZ Regimens in GBM Patients: An Experience with MGMT Exploratory Evaluation
por: Napoleoni, Luca, et al.
Publicado: (2019)

Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practice
por: Cortellini, Alessio, et al.
Publicado: (2019)

Multicentric retrospective analysis of platinum‐pemetrexed regimens as first‐line therapy in non‐squamous non‐small cell lung cancer patients: A “snapshot” from clinical practice
por: Cortellini, Alessio, et al.
Publicado: (2017)

The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy
por: Mattei, Vincenzo, et al.
Publicado: (2021)

Evaluation of Second-Line Anti-VEGF after First-Line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter “SLAVE” Study
por: Parisi, Alessandro, et al.
Publicado: (2020)

Hypoxia-Mimetic CoCl(2) Agent Enhances Pro-Angiogenic Activities in Ovine Amniotic Epithelial Cells-Derived Conditioned Medium
por: Di Mattia, Miriam, et al.
Publicado: (2022)

Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx)
por: Bruera, Gemma, et al.
Publicado: (2013)

Utilization Behavior: What Is Known and What Has to Be Known?
por: Iaccarino, Leonardo, et al.
Publicado: (2014)

Anti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer
por: da Paz, Mariana Campos, et al.
Publicado: (2012)

Epigenetic Influences in the Obesity/Colorectal Cancer Axis: A Novel Theragnostic Avenue
por: Ayers, Duncan, et al.
Publicado: (2019)

"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II study
por: Bruera, Gemma, et al.
Publicado: (2010)

Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors
por: Cimini, Andrea, et al.
Publicado: (2020)

Shifting emphasis from pharmacogenomics to theragnostics
por: Ozdemir, Vural, et al.
Publicado: (2006)

Bacteriophages as Solid Tumor Theragnostic Agents
por: Veeranarayanan, Srivani, et al.
Publicado: (2021)

Molecular Imaging and Theragnostics of Thyroid Cancers
por: Giovanella, Luca, et al.
Publicado: (2022)

Aptamers as Theragnostic Tools in Prostate Cancer
por: Cruz-Hernández, Carlos David, et al.
Publicado: (2022)

Catching What We Can't See: Manual Interception of Occluded Fly-Ball Trajectories
por: Bosco, Gianfranco, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_rh6rrmq3nkdcp05mok3hubn6mf